HIGHLIGHTS
Hims AND Hers both hit all-time-high weekly web traffic in the same week (week ending May 17) 🤯
Hims has reclaimed the web traffic lead from Ro, and is now growing faster y/y (+27% vs +19%)
Hers iOS app just posted its best-ever weekly rank in the app store (#11) 🔥
Hers continues to outrank Hims, full stop -- ahead on both the latest week (#11 vs #19) and the 30-day average (#13 vs #21)
Every telehealth app we track climbed this week: Hims, Hers, Ro, and One Medical all improved, and even cellar-dweller LifeMD bounced 30 spots (#195 → #165) though still >100 spots below the rest
Y/y sales now positive 3 of the last 4 weeks. Paired with the strong web traffic + app rankings, it looks like the long-awaited “reacceleration” might finally be here
Hims Meta ads pivoted hard back to !@#$; Hers is leaning into weight loss (now well over half its ads)
“ Hims is a flop” “ Hims is going back to 16” is what everyone was saying a month ago and while it was taking a beating. Happy to see that the company has proved them wrong.
Continuous growth and continuous development since then. Props to all those that didn’t sell and held conviction!
News: Hims & Hers launches generics for Novo’s semaglutide in Canada
Corgen
2 weken geleden
Bad news and PERCIEVED bad news
So I have been trying to answer the question:
What are the real bad news
and what are just "feels bad" news
The bad thing is that the "feel bad" will win in short term and do fine in long term provided that good news follow.
The problem now is that all these recent news kinda throw Hims into a stagnation / falling price action. That fact will feed itself back and it will not fly up unless some really good news come which I don't see will happen for a while.
Short term bad news will move the price fast.
The long-term proposition is now little less sure in my eyes because any more bad news now will send the stock into free fall.
As this is only a 10% of my portfolio, I will be leaving this stock as it is and not add more.
Will see what happens for the next 3 months before another earnings report.
If price should start recovering, I will return to this and start thinking about buying more.
I am just not certain atm about short term price movements.
Any well reasoned prognoses from long-term investors in here?
As much as I like HIMS, this is such a bad management move. The convertible loans will dilute share holders and share earnings. Furthermore, they previously said they would fund the eucalyptus acquisition through a strong cash balance. So are we just going to pretend they didn’t change their narrative? This company went from 0 debt and a good cash flow to now expanding rapidly whilst margins have depleted and other players are aggressively entering the space.
If they had the same organic growth they had a year ago, this expansion would be justified. But the board of members are selling their shares and now deciding to spend 300 million diluting share holders whilst they spent more on buy backs at twice the current price. Management is absolutely terrible.
They need to spend on better social media marketing and a better user experience because the website sucks (doesn’t allow you to browse products and instantly wants all your details before you can even check what the products are) and so does their social media platforms, sterile and always the same vague basic posts. They’re just spending on irrelevant things it seems.
Corgen
3 weken geleden
Earnings - my first digestion stage
After digesting the earnings
After seeing the whole market drop today and Hims pretty much flat...
I am beginning to feel more secure in the mid to long-term.
Was aiming to add at $24 after earnings and it hasn't fallen there again yet.
Started acquiring 3x longs which fell 48% and I managed to but at -40% so I am 8% down.
Will be adding on previous dip points.
Always keeping enough cash to buy and average down massively if "tihs" (read bcckwards) hits the fan.
Keeping my position at 10% so the 90% can very well average down my long position in the worst case scenario.
This way my gains if price recovers are starting at 10% but I can add on the way up as well so effectively keeping my long in safety. Not gonna try to buy with 100% and hope to hit the bottom. Never works.
Deze pagina kan door community's gemaakte inhoud bevatten waarvoor Trading 212 niet verantwoordelijk is. Doe altijd je eigen onderzoek. Trading 212 is uitsluitend gericht op orderuitvoering. Wij bieden geen beleggingsadvies of portefeuillebeheer.
Vermogen opbouwen is een gewoonte. Automatiseer je groei aan de hand van een pie.
Beleg volgens kant-en-klare pies, of stel je eigen verdeling samen uit duizenden aandelen en ETF's
Meer informatie
Meer informatie
Bekijk de video
Beleg zelfs in de duurste aandelen zoals Google, Amazon en Apple.
Bekijk de video
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Bekijk alle handelsinstrumenten
24/7-ondersteuning
Gemiddeld binnen 29 seconden reactie
Begin nu vermogen op te bouwen
Sluit je aan bij 5 miljoen gebruikers
Download de app
Rekening openen
Download de mobiele app
Alle gepresenteerde statistieken zijn wereldwijd. Het aantal klanten vertegenwoordigt gefinancierde Accounts.
Uitstekend
Beoordeeld met 4,6 / 5 op basis van 93.595 beoordelingen op
Trustpilot
Beoordeeld met 4,6 / 5 op basis van 93.595 beoordelingen op
Trustpilot
Uitgenodigd
Great
Immediate updates, easy to use and manage.
Uitgenodigd
Very easy to use
Very easy to use. Intuitive app and makes it straight forward to sit back and let your investment's do its work
Uitgenodigd
Ease of use
Easy to set up an account
Easy to transfer funds
Great interest rate
Great all round experience
Uitgenodigd
Easy to set up my account
Easy to set up my account easy to access balance and a very good rate in interest.
Uitgenodigd
easy to use platform
easy to use platform, love the ability to transfer cash isa funds into stocks and shares isa
Uitgenodigd
Simple and Informative platform
I wanted a platform which was offering great rates for my ISA, but discovered not only did this platform do that. It also gave me an insight into trading and world markets. It's quite simply brilliant.
Uitgenodigd
Great app that provides all my account…
Great app that provides all my account info at my fingertips
Uitgenodigd
Easy to use.
Easy to use.
Can view everything simply.
Just what I need.
Uitgenodigd
Good interest rate and can take the…
Good interest rate and can take the money out whenever I want.
Uitgenodigd
So easy
So easy! Makes investing a pleasure
Uitgenodigd
I’m novice and useless with technology…
I’m novice and useless with technology but I found this an easy site to navigate and to deal with.
Uitgenodigd
Nice app
Great app, very intuitive and simple to use. Gold standard.
Uitgenodigd
Very easy to use
Very easy to use. Very clear. And a joy to watch my savings rise
Uitgenodigd
Easy to use
Functional and easy to use and track my cash & stocks & shares isas
Uitgenodigd
Easy access to my account and how Easy…
Easy access to my account and how Easy it is to navigate the212 application.
Uitgenodigd
Simple and easy to use app
Simple and easy to use app. Ease of setting up recurring payments. Great for a beginner that has no prior knowledge or experience of investing.
Uitgenodigd
Easy and simple app
Easy and simple app, tells you daily your interest which I like and I get emails. The updating is really good.
Uitgenodigd
Very easy and highly recommend
Very easy and highly recommend. Straight forward to use and cost instructions on the fees and charges.
Uitgenodigd
Great way for your money to build
Just very pleased with the level of savings rate and steady build up.
Uitgenodigd
Cool app
User friendly mobile app that makes investing easy and funny. Fast navigation throughout the app. In a few clicks can see basically every information one might require.
Dit is een aantal positieve klantbeoordelingen
Onze toekenningen
Veelgestelde vragen
Wat is de aandelenkoers van Hims & Hers Health (HIMS)?
De huidige prijs van Hims & Hers Health (HIMS) is $ 28,99.
Wat is de hoogste koers in 52 weken van HIMS?
De hoogste koers in 52 weken voor HIMS is $ 70,46.
Wat is het 52-weeks dieptepunt van HIMS?
Het 52-weeks dieptepunt voor HIMS is $ 13,72.
Wat is de wekelijkse prestatie van HIMS?
In de afgelopen week is de prijs van HIMS veranderd met 14,22%.
Wat is de maandelijkse prestatie van HIMS?
In de afgelopen maand is de prijs van HIMS veranderd met 5,76%.
Wat is de 3-maandsrendement van HIMS?
In de afgelopen drie maanden is de prijs van HIMS met 83,25% veranderd.
Wat is het rendement over 6 maanden van HIMS?
In de afgelopen zes maanden is de prijs van HIMS met -21,8%veranderd.
Wat is de jaarlijkse prestatie van HIMS?
In het afgelopen jaar is de prijs van HIMS veranderd met -47,03%.